(S1 (S (S (NP (NP (JJ Phenolic) (NN fraction)) (PP (IN of) (NP (NN tobacco) (NN smoke) (NN condensate)))) (VP (VBZ potentiates) (NP (NN benzo-LSB-a-RSB-pyerene) (NN diol) (JJ epoxide-induced) (NN cell) (NN transformation))) (: :) (NP (NP (NN role)) (PP (IN of) (NP (NN protein) (NN kinase) (NN C))))) (. .)))
(S1 (S (PP (IN In) (NP (DT this) (NN study))) (NP (PRP we)) (VP (VP (VBN separated) (NP (ADJP (RB weakly) (JJ acidic)) (JJ phenolic) (NNS components)) (PP (IN from) (NP (NP (JJ other) (ADJP (ADJP (JJ neutral)) (, ,) (ADJP (JJ acidic)) (CC and) (ADJP (JJ basic))) (NNS components)) (PP (IN of) (NP (NP (NN tobacco) (NN smoke) (NN condensate)) (PRN (-LRB- -LRB-) (NP (NN TSC)) (-RRB- -RRB-))))))) (CC and) (VP (VBD observed) (SBAR (IN that) (S (NP (NP (JJ phenolic) (NN fraction)) (PP (IN of) (NP (NNS TSC)))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS colonies)) (PP (IN of) (NP (NP (JJ promotion-sensitive) (NN JB6) (NN Cl41) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBD showed) (NP (NP (JJ anchorage-independent) (NN growth)) (PP (IN on) (NP (JJ soft) (NN agar))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN BPDE)) (PRN (-LRB- -LRB-) (NP (NP (DT an) (JJ ultimate) (NN carcinogen)) (VP (VBN produced) (PP (IN by) (NP (NP (JJ metabolic) (NN activation)) (PP (IN of) (NP (DT the) (NN PAH) (NN benzo-LSB-a-RSB-pyrene))))))) (-RRB- -RRB-)))))))))))))))))))) (. .)))
(S1 (S (S (NP (JJ Anchorage-independent) (NN cell) (NN growth)) (VP (VBZ is) (ADJP (JJ indicative) (PP (IN of) (NP (NP (NN cell) (NN transformation)) (VP (VBG resulting) (PP (IN in) (NP (NP (NN acquisition)) (PP (IN of) (NP (JJ tumorigenic) (NN potential))))))))))) (. .)))
(S1 (S (SBAR (IN In) (NN order) (TO to) (S (VP (VB understand) (NP (NP (DT the) (VBG underlying) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN TSC) (JJ phenolic) (NN fraction)) (VP (VBZ potentiates) (NP (JJ BPDE-induced) (NN tumorigenicity))))))))) (, ,) (NP (PRP we)) (VP (VBD examined) (NP (NP (PRP$ its) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NP (CD two) (NN transcription) (NNS factors)) (NP (NP (NN AP-1)) (CC and) (NP (NN NF-kappaB)))) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN influenced) (PP (IN by) (NP (JJ established) (NN tumor) (NN promoter) (NN TPA))))))))))))))))) (. .)))
(S1 (S (S (S (NP (NN BPDE) (NN treatment)) (VP (VBD caused) (NP (NP (NN induction)) (PP (IN of) (NP (NP (CC both) (NP (NN AP-1)) (CC and) (NP (NN NF-kappaB))) (NN activity)))) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NN luciferase) (NN reporter) (NN assay)))))))) (CC and) (S (NP (NP (JJ only) (NN NF-kappaB) (NN induction)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN BPDE)))))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN attenuated) (PP (IN by) (NP (ADJP (NN TSC) (JJ phenolic)) (NN fraction)))) (SBAR (IN whereas) (S (NP (NN AP-1) (NN induction)) (VP (VBZ remains) (ADJP (JJ unaltered)))))))) (. .)))
(S1 (S (S (NP (NP (NN Attenuation)) (PP (IN of) (NP (NN NF-kappaB) (NN activation))) (PP (IN by) (NP (NN TSC) (JJ phenolic) (NN fraction)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (JJ significant) (NN decrease)) (PP (IN of) (NP (JJ intracellular) (NN PKC) (NN substrate) (NN phosphorylation))) (PP (IN in) (NP (JJ BPDE) (JJ treated) (NNS cells)))))))) (. .)))
(S1 (S (S (NP (NP (NP (JJ Non-specific) (NN PKC) (NNS inhibitors)) (NP (NP (NN staurosporine)) (CC and) (NP (NN bisindolylmaleimide) (CD II)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS inhibitors)) (ADJP (JJ specific) (PP (TO to) (NP (NP (NP (JJ conventional) (NNS PKCs)) (PRN (-LRB- -LRB-) (NP (NN Go6976)) (-RRB- -RRB-))) (CC and) (NP (NP (NN PKC-delta)) (PRN (-LRB- -LRB-) (NP (NN rottlerin)) (-RRB- -RRB-)))))))) (VP (VBD attenuated) (NP (NN NF-kappaB) (NN activation)) (PP (IN in) (NP (JJ BPDE) (JJ treated) (NNS cells))) (PP (TO to) (NP (DT a) (JJ varying) (NN degree))) (S (VP (VBG indicating) (NP (NP (DT a) (JJ possible) (NN link)) (PP (IN between) (NP (NP (NN PKC) (NN down-regulation)) (CC and) (NP (NP (DT the) (NN attenuation)) (PP (IN of) (NP (NN NF-kappaB) (NN activity))) (PP (IN by) (NP (NN TSC) (JJ phenolic) (NN fraction))))))))))) (. .)))
(S1 (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (NNS cells))) (PP (IN with) (NP (NN PKC) (NNS inhibitors)))) (ADVP (RB also)) (VP (VBD potentiated) (NP (NP (JJ anchorage-independent) (NN growth)) (PP (IN of) (NP (JJ BPDE) (JJ treated) (NNS cells))) (PP (IN on) (NP (JJ soft) (NN agar)))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (NP (NP (DT a) (JJ possible) (NN role)) (PP (IN of) (NP (NN PKC) (NN down-regulation))) (PP (IN in) (NP (NP (NN potentiation)) (PP (IN of) (NP (JJ BPDE-induced) (NN tumorogenicity))) (PP (IN by) (NP (NN TSC) (JJ phenolic) (NN fraction)))))))) (. .)))
